Ignite Creation Date:
2024-05-06 @ 5:43 PM
Last Modification Date:
2024-10-26 @ 2:34 PM
Study NCT ID:
NCT05403138
Status:
RECRUITING
Last Update Posted:
2023-06-27
First Post:
2022-05-30
Brief Title:
Safety and Efficacy of Daratumumab in Patients With Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorders
Sponsor:
Tianjin Medical University General Hospital
Organization:
Tianjin Medical University General Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-11-01
Start Date Type:
ACTUAL
Primary Completion Date:
2024-08-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-10-01
Completion Date Type:
ESTIMATED
First Submit Date:
2022-05-30
First Submit QC Date:
May 30 2022
Study First Post Date:
2022-06-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-24
Last Update Post Date:
2023-06-27
Last Update Post Date Type:
ACTUAL